Literature DB >> 34880481

Aggregates of TDP-43 protein spiral into view.

Hana M Odeh, James Shorter.   

Abstract

Entities:  

Keywords:  Neurodegeneration; Structural biology

Mesh：

Substances：

Year:  2022        PMID： 34880481     DOI： 10.1038/d41586-021-03605-0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   69.504


× No keyword cloud information.
  9 in total

1.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

2.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Tetsuaki Arai; Masato Hasegawa; Haruhiko Akiyama; Kenji Ikeda; Takashi Nonaka; Hiroshi Mori; David Mann; Kuniaki Tsuchiya; Mari Yoshida; Yoshio Hashizume; Tatsuro Oda
Journal:  Biochem Biophys Res Commun       Date:  2006-10-30       Impact factor: 3.575

3.  Structure of pathological TDP-43 filaments from ALS with FTLD.

Authors:  Diana Arseni; Masato Hasegawa; Alexey G Murzin; Fuyuki Kametani; Makoto Arai; Mari Yoshida; Benjamin Ryskeldi-Falcon
Journal:  Nature       Date:  2021-12-08       Impact factor: 69.504

4.  TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity.

Authors:  Brian S Johnson; David Snead; Jonathan J Lee; J Michael McCaffery; James Shorter; Aaron D Gitler
Journal:  J Biol Chem       Date:  2009-05-22       Impact factor: 5.157

Review 5.  FUS and TDP-43 Phases in Health and Disease.

Authors:  Bede Portz; Bo Lim Lee; James Shorter
Journal:  Trends Biochem Sci       Date:  2021-01-11       Impact factor: 13.807

6.  Structure-based classification of tauopathies.

Authors:  Yang Shi; Wenjuan Zhang; Yang Yang; Alexey G Murzin; Benjamin Falcon; Abhay Kotecha; Mike van Beers; Airi Tarutani; Fuyuki Kametani; Holly J Garringer; Ruben Vidal; Grace I Hallinan; Tammaryn Lashley; Yuko Saito; Shigeo Murayama; Mari Yoshida; Hidetomo Tanaka; Akiyoshi Kakita; Takeshi Ikeuchi; Andrew C Robinson; David M A Mann; Gabor G Kovacs; Tamas Revesz; Bernardino Ghetti; Masato Hasegawa; Michel Goedert; Sjors H W Scheres
Journal:  Nature       Date:  2021-09-29       Impact factor: 49.962

7.  TDP-43 and RNA form amyloid-like myo-granules in regenerating muscle.

Authors:  Thomas O Vogler; Joshua R Wheeler; Eric D Nguyen; Michael P Hughes; Kyla A Britson; Evan Lester; Bhalchandra Rao; Nicole Dalla Betta; Oscar N Whitney; Theodore E Ewachiw; Edward Gomes; James Shorter; Thomas E Lloyd; David S Eisenberg; J Paul Taylor; Aaron M Johnson; Bradley B Olwin; Roy Parker
Journal:  Nature       Date:  2018-10-31       Impact factor: 49.962

8.  Structures of α-synuclein filaments from multiple system atrophy.

Authors:  Manuel Schweighauser; Yang Shi; Airi Tarutani; Fuyuki Kametani; Alexey G Murzin; Bernardino Ghetti; Tomoyasu Matsubara; Taisuke Tomita; Takashi Ando; Kazuko Hasegawa; Shigeo Murayama; Mari Yoshida; Masato Hasegawa; Sjors H W Scheres; Michel Goedert
Journal:  Nature       Date:  2020-05-27       Impact factor: 49.962

9.  TDP-43 condensation properties specify its RNA-binding and regulatory repertoire.

Authors:  Martina Hallegger; Anob M Chakrabarti; Flora C Y Lee; Bo Lim Lee; Aram G Amalietti; Hana M Odeh; Katie E Copley; Jack D Rubien; Bede Portz; Klara Kuret; Ina Huppertz; Frédérique Rau; Rickie Patani; Nicolas L Fawzi; James Shorter; Nicholas M Luscombe; Jernej Ule
Journal:  Cell       Date:  2021-08-10       Impact factor: 41.582
  9 in total
  1 in total

1.  Long-Term Sequelae of COVID-19 in Experimental Mice.

Authors:  Michael J Paidas; Daniela S Cosio; Saad Ali; Norma Sue Kenyon; Arumugam R Jayakumar
Journal:  Mol Neurobiol       Date:  2022-07-13       Impact factor: 5.682
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.